| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H13ClN4 |
| Molecular Weight | 224.69 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=NN=C(C=C1)N2C[C@@H]3CC[C@H](C2)N3
InChI
InChIKey=USXYDBGSWSSTGE-OCAPTIKFSA-N
InChI=1S/C10H13ClN4/c11-9-3-4-10(14-13-9)15-5-7-1-2-8(6-15)12-7/h3-4,7-8,12H,1-2,5-6H2/t7-,8+
| Molecular Formula | C10H13ClN4 |
| Molecular Weight | 224.69 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DBO-83 is a 3,8-diazabicyclo[3.2.1]octane derivative with
antinociceptive properties. DBO-83 exhibits high affinity for the α4β2 subtype and is a full agonist at α4β2 and ganglionic receptors but lacks appreciable activity at neuromuscular receptors. DBO-83 exhibits antinociceptive activity in both rat and mouse models of acute and persistent
pain. In addition DBO-83 modulates memory functions in rodents.
